Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer.
Breast Cancer Res Treat
; 150(3): 605-11, 2015 Apr.
Article
en En
| MEDLINE
| ID: mdl-25833209
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Vitamina D
/
Neoplasias de la Mama
/
Protocolos de Quimioterapia Combinada Antineoplásica
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Female
/
Humans
/
Middle aged
Idioma:
En
Año:
2015
Tipo del documento:
Article